CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
O-POINTED is a novel tool designed to personalize the drug development process for osteoarthritis by using patient-derived cell lines. It addresses the complexity of the disease and aims to improve drug response rates by incorporating patient variability into testing.
Osteoarthritis is the fastest growing cause of disability worldwide.
Still, there is currently no drug available that targets the underlying pathophysiology of osteoarthritis.
Clinical trials testing disease-modifying drug candidates consistently fail.
This is because osteoarthritis is a complex disease and currently used drug development tools completely disregard patient variability.
Consequently, such non-personalised drugs fail to reach high enough response rates in highly variable osteoarth…
InSCREENeX GmbH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
